Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (2)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (1)
- (3)
- (2)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (6)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (13)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
CERILLIANT™ Alprazolam Solution, 1.0 mg/mL in methanol, Sold by MilliporeSigma™ Supelco™
This certified reference standard is suitable for use in a wide variety of LC/MS or GC/MS testing applications from forensic analysis and clinical toxicology to urine drug testing and pain prescription monitoring.
CERILLIANT™ Acetyl fentanyl-13C6 Solution, 50 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
CERILLIANT™ Multicomponent Alcohol Mix 4000, 4000 μg/mL each component in H2O, Sold by MilliporeSigma™ Supelco™
A multicomponent calibration kit containing acetone, ethanol, isopropanol, and methanol at a concentration of 4000 μg/mL. This kit is suitable for calibration of blood alcohol testing methods using GC Headspace.
CERILLIANT™ Opiate Multi-component Mixture-5 Solution, 250 μg/mL each component in methanol, Sold by MilliporeSigma™ Supelco™
A Certified Spiking Solution™ of routinely tested opiates (±)-methadone, codeine, hydrocodone, meperidine and oxycodone.
CERILLIANT™ alpha-Hydroxyalprazolam-d5 Solution, 1.0 mg/mL in methanol, Sold by MilliporeSigma™ Supelco™
This stable-labeled internal standard is suitable for quantitation of α-hydroxyalprazolam levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or isotope dilution methods.
CERILLIANT™ Pain Management Multi-component Opiate Mixture-13 Solution, 100 μg/mL each, Sold by MilliporeSigma™ Supelco™
A multi-component mix containing opiates methadone, buprenorphine, tramadol, codeine, fentanyl, hydrocodone, meperidine, morphine, naloxone, naltrexone, oxycodone, and oxymorphone. This certified solution mix is suitable for numerous applications from pain prescription monitoring, clinical toxicology, and forensic analysis to urine drug testing.
CERILLIANT™ Carfentanil-D5 Oxalate Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™
Certified reference material
CERILLIANT™ (±)-Amphetamine-d5 (deuterium label on side chain) Solution, 100 μg/mL, Sold by MilliporeSigma™ Supelco™
Suitable for quantitation of amphetamine levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or sports testing.
CERILLIANT™ Cocaine Solution, 1.0 mg/mL in acetonitrile, Sold by MilliporeSigma™ Supelco™
A Certified Spiking Solution™ suitable for use in LC/MS or GC/MS testing applications for forensic analysis, urine drug testing, or clinical toxicology.
CERILLIANT™ Catecholamine Mix 1 (Epinephrines) Solution, 1.0 mg/mL each in methanol (as free base), Sold by MilliporeSigma™ Supelco™
A Certified Spiking Solution™ of (±)-Epinephrine HCl and (±)-Norepinephrine HCl. This multi-component mix is suitable for use in preparation of linearity standards, calibrators, or controls in addition to other critical quantitative applications such as internal proficiency testing or OEM use in preparation of reagents, assay development, and instrument IQ/OQ.
CERILLIANT™ Nordiazepam-d5 Solution, 1 mg/mL in methanol, Sold by MilliporeSigma™ Supelco™
This stable-labeled internal standard is suited for quantitation of nordiazepam levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis or isotope dilution methods.
CERILLIANT™ Amine Mixture-6 Solution, 250 μg/mL each component in methanol, Sold by MilliporeSigma™ Supelco™
A multi-component mix containing amphetamine and phenethylamine class drugs MDEA, MDMA, methamphetamine, amphetamine, MDA and phenetermine.